(Q43758645)

26 November 2017

title

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy (English)

1 reference

26 November 2017

0 references

1 reference

1 reference

1 reference

placebo-controlled trial

1 reference

1 reference

2

1 reference

26 November 2017

Howell SJ

1

1 reference

26 November 2017

Adams JE

3

1 reference

26 November 2017

Smets EM

4

1 reference

26 November 2017

Warburton R

5

1 reference

26 November 2017

Shalet SM

6

1 reference

26 November 2017

language of work or name

1 reference

1 September 2001

1 reference

26 November 2017

published in

Clinical Endocrinology

1 reference

26 November 2017

volume

55

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

315-324

1 reference

Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Issues in testosterone replacement in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Cross-calibration of liquid and solid QCT calibration standards: corrections to the UCSF normative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Reduced bone mineral density in men following chemotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Secondary hypogonadism in older men: its relation to impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Plasma free testosterone--is an index sufficient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Serum testosterone and its relation to bone mineral density and body composition in normal males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Elevated serum lipids in hypogonadal men with and without hyperprolactinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Interpretation of bone densitometry measurements: disadvantages of a percentage scale and a discussion of some alternatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Screening for adjustment disorders and major depressive disorders in cancer in-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Is postmenopausal bone loss an age-related phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01297.X

10.1046/J.1365-2265.2001.01297.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference